Zydus Lifesciences has achieved a significant milestone with the final approval from the US Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets, 75 mg and 100 mg. This approval grants the company a competitive edge in the US market, reinforcing its presence in the pharmaceutical industry. Final Approval Granted for Manufacturing Zydus Lifesciences has …